Titan Pharmaceuticals (NASDAQ:TTNP) Share Price Crosses Below 200 Day Moving Average – What’s Next?

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $6.07 and traded as low as $4.26. Titan Pharmaceuticals shares last traded at $4.30, with a volume of 12,361 shares traded.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on Titan Pharmaceuticals in a research report on Thursday. They set a “sell” rating on the stock.

Titan Pharmaceuticals Price Performance

The business has a 50-day moving average of $5.54 and a 200-day moving average of $6.03.

Titan Pharmaceuticals (NASDAQ:TTNP) last announced its earnings results on Thursday, August 15th. The specialty pharmaceutical company reported ($2.29) earnings per share (EPS) for the quarter.

Titan Pharmaceuticals Company Profile

Titan Pharmaceuticals, Inc, a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder.